JANUS HENDERSON GROUP PLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 167 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5,177,133
-7.2%
112,580
+16.0%
0.00%0.0%
Q2 2023$5,578,394
+43.1%
97,075
-6.6%
0.00%0.0%
Q1 2023$3,897,198
+1704.7%
103,941
+1247.3%
0.00%
Q4 2022$215,950
-0.5%
7,7150.0%0.00%
Q3 2022$217,000
-19.6%
7,715
-0.7%
0.00%
Q2 2022$270,000
-97.9%
7,767
-97.9%
0.00%
-100.0%
Q1 2022$13,049,000
-42.4%
363,504
-62.6%
0.01%
-33.3%
Q4 2021$22,666,000
+22.9%
973,193
+0.3%
0.01%
+12.5%
Q3 2021$18,450,000
+64.9%
970,551
+74.9%
0.01%
+60.0%
Q2 2021$11,190,000555,0360.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders